Sensus Healthcare, Inc. Revenue
Sensus Healthcare, Inc. (SRTS) reported Revenue of $2.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2026-08-14
- Sensus Healthcare, Inc. revenues for the quarter ending 2026-06-30 was $2.29M, a 68.69% decline year-over-year.
- Sensus Healthcare, Inc. revenues for the quarter ending 2026-03-31 was $3.39M, a 59.32% decline year-over-year.
- Sensus Healthcare, Inc. revenues for the quarter ending 2025-12-31 was $4.94M, a 62.20% decline year-over-year.
- Sensus Healthcare, Inc. revenues for the quarter ending 2025-09-30 was $6.88M, a 22.12% decline year-over-year.
- Sensus Healthcare, Inc. revenues for fiscal 2025 was $27.48M, a 34.26% decline from fiscal 2024.
- Sensus Healthcare, Inc. revenues for fiscal 2024 was $41.81M, a 71.31% increase from fiscal 2023.
- Sensus Healthcare, Inc. revenues for fiscal 2023 was $24.41M, a 45.20% decline from fiscal 2022.
- Sensus Healthcare, Inc. revenues for fiscal 2022 was $44.53M, a 64.68% increase from fiscal 2021.
| Period end | Revenues | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.29M 10-Q · filed 2026-08-14 | $5.68M 10-Q · filed 2026-08-14 | $10.62M derived: sum of 3 quarters · filed 2026-08-14 | $17.51M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | $3.39M 10-Q · filed 2026-05-13 | $8.33M derived: sum of 2 quarters · filed 2026-05-13 | $15.22M derived: sum of 3 quarters · filed 2026-05-13 | $22.53M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $11.82M derived: sum of 2 quarters · filed 2026-03-04 | $19.14M derived: sum of 3 quarters · filed 2026-08-14 | $27.48M 10-K · filed 2026-03-04 | |||||
| 2025-09-30 | $6.88M 10-Q · filed 2025-11-12 | $14.20M derived: sum of 2 quarters · filed 2026-08-14 | $22.54M 10-Q · filed 2025-11-12 | $35.61M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | $7.32M 10-Q · filed 2026-08-14 | $15.66M 10-Q · filed 2026-08-14 | $28.73M derived: sum of 3 quarters · filed 2026-08-14 | $37.56M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | $8.34M 10-Q · filed 2026-05-13 | $21.41M derived: sum of 2 quarters · filed 2026-05-13 | $30.25M derived: sum of 3 quarters · filed 2026-05-13 | $39.49M derived: sum of 4 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | $13.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $21.91M derived: sum of 2 quarters · filed 2026-03-04 | $31.14M derived: sum of 3 quarters · filed 2026-03-04 | $41.81M 10-K · filed 2026-03-04 | |||||
| 2024-09-30 | $8.84M 10-Q · filed 2025-11-12 | $18.08M derived: sum of 2 quarters · filed 2025-11-12 | $28.74M 10-Q · filed 2025-11-12 | $41.31M derived: sum of 4 quarters · filed 2025-11-12 | |||||
| 2024-06-30 | $9.24M 10-Q · filed 2025-08-12 | $19.90M 10-Q · filed 2025-08-12 | $32.47M derived: sum of 3 quarters · filed 2025-08-12 | $36.37M derived: sum of 4 quarters · filed 2025-08-12 | |||||
| 2024-03-31 | $10.66M 10-Q · filed 2025-05-15 | $23.23M derived: sum of 2 quarters · filed 2025-05-15 | $27.13M derived: sum of 3 quarters · filed 2025-05-15 | $31.66M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $12.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $16.46M derived: sum of 2 quarters · filed 2025-03-05 | $20.99M derived: sum of 3 quarters · filed 2025-03-05 | $24.41M 10-K · filed 2025-03-05 | |||||
| 2023-09-30 | $3.90M 10-Q · filed 2024-11-14 | $8.43M derived: sum of 2 quarters · filed 2024-11-14 | $11.84M 10-Q · filed 2024-11-14 | $24.94M derived: sum of 4 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | $4.53M 10-Q · filed 2024-08-13 | $7.94M 10-Q · filed 2024-08-13 | $21.05M derived: sum of 3 quarters · filed 2024-08-13 | $30.05M derived: sum of 4 quarters · filed 2024-08-13 | |||||
| 2023-03-31 | $3.41M 10-Q · filed 2024-05-10 | $16.52M derived: sum of 2 quarters · filed 2024-05-10 | $25.53M derived: sum of 3 quarters · filed 2024-05-10 | $37.61M derived: sum of 4 quarters · filed 2024-05-10 | |||||
| 2022-12-31 | $13.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $22.11M derived: sum of 2 quarters · filed 2024-03-15 | $34.19M derived: sum of 3 quarters · filed 2024-03-15 | $44.53M 10-K · filed 2024-03-15 | |||||
| 2022-09-30 | $9.01M 10-Q · filed 2023-11-13 | $21.09M derived: sum of 2 quarters · filed 2023-11-13 | $31.43M 10-Q · filed 2023-11-13 | $44.45M derived: sum of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | $12.08M 10-Q · filed 2023-08-11 | $12.08M 10-Q · filed 2023-08-11 | $22.42M 10-Q · filed 2023-08-11 | $35.44M derived: sum of 3 quarters · filed 2023-08-11 | $40.97M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $10.34M 10-Q · filed 2023-05-12 | $23.36M derived: sum of 2 quarters · filed 2023-05-12 | $28.89M derived: sum of 3 quarters · filed 2023-05-12 | $34.31M derived: sum of 4 quarters · filed 2023-05-12 | |||||
| 2021-12-31 | $13.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $18.55M derived: sum of 2 quarters · filed 2023-03-23 | $23.97M derived: sum of 3 quarters · filed 2023-03-23 | $27.04M 10-K · filed 2023-03-23 | |||||
| 2021-09-30 | $5.53M 10-Q · filed 2022-11-10 | $10.95M derived: sum of 2 quarters · filed 2022-11-10 | $14.02M 10-Q · filed 2022-11-10 | $19.11M derived: sum of 4 quarters · filed 2022-11-10 | |||||
| 2021-06-30 | $5.42M 10-Q · filed 2022-08-12 | $8.49M 10-Q · filed 2022-08-12 | $13.59M derived: sum of 3 quarters · filed 2022-08-12 | $15.21M derived: sum of 4 quarters · filed 2022-08-12 | |||||
| 2021-03-31 | $3.07M 10-Q · filed 2022-05-12 | $8.16M derived: sum of 2 quarters · filed 2022-05-12 | $9.78M derived: sum of 3 quarters · filed 2022-05-12 | $10.97M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $6.71M derived: sum of 2 quarters · filed 2022-03-25 | $7.90M derived: sum of 3 quarters · filed 2022-03-25 | $9.58M 10-K · filed 2022-03-25 | $9.58M 10-K · filed 2021-03-05 | ||||
| 2020-09-30 | $1.62M 10-Q · filed 2021-11-10 | $1.62M 10-Q · filed 2020-11-10 | $2.80M derived: sum of 2 quarters · filed 2021-11-10 | $4.48M 10-Q · filed 2021-11-10 | $4.48M 10-Q · filed 2020-11-10 | $12.99M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $1.18M 10-Q · filed 2021-08-13 | $1.18M 10-Q · filed 2020-08-10 | $2.86M 10-Q · filed 2021-08-13 | $2.86M 10-Q · filed 2020-08-10 | $11.37M derived: sum of 3 quarters · filed 2021-08-13 | $17.21M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $1.68M 10-Q · filed 2021-05-14 | $1.68M 10-Q · filed 2020-05-11 | $10.19M derived: sum of 2 quarters · filed 2021-05-14 | $16.03M derived: sum of 3 quarters · filed 2021-05-14 | $23.51M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $8.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $14.35M derived: sum of 2 quarters · filed 2021-03-05 | $21.83M derived: sum of 3 quarters · filed 2021-03-05 | $27.26M 10-K · filed 2021-03-05 | |||||
| 2019-09-30 | $5.84M 10-Q · filed 2020-11-10 | $13.32M derived: sum of 2 quarters · filed 2020-11-10 | $18.75M 10-Q · filed 2020-11-10 | $26.83M derived: sum of 4 quarters · filed 2020-11-10 | |||||
| 2019-06-30 | $7.48M 10-Q · filed 2020-08-10 | $12.91M 10-Q · filed 2020-08-10 | $20.99M derived: sum of 3 quarters · filed 2020-08-10 | $27.33M derived: sum of 4 quarters · filed 2020-08-10 | |||||
| 2019-03-31 | $5.44M 10-Q · filed 2020-05-11 | $13.52M derived: sum of 2 quarters · filed 2020-05-11 | $19.85M derived: sum of 3 quarters · filed 2020-05-11 | $25.91M derived: sum of 4 quarters · filed 2020-05-11 | |||||
| 2018-12-31 | $8.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $14.41M derived: sum of 2 quarters · filed 2020-03-06 | $20.47M derived: sum of 3 quarters · filed 2020-03-06 | $26.43M 10-K · filed 2020-03-06 | |||||
| 2018-09-30 | $6.33M 10-Q · filed 2019-11-08 | $12.39M derived: sum of 2 quarters · filed 2019-11-08 | $18.35M 10-Q · filed 2019-11-08 | $24.82M derived: sum of 4 quarters · filed 2019-11-08 | |||||
| 2018-06-30 | $6.06M 10-Q · filed 2019-08-12 | $12.01M 10-Q · filed 2019-08-12 | $18.48M derived: sum of 3 quarters · filed 2019-08-12 | $23.28M derived: sum of 4 quarters · filed 2019-08-12 | |||||
| 2018-03-31 | $5.96M 10-Q · filed 2019-05-14 | $12.43M derived: sum of 2 quarters · filed 2019-05-14 | $17.22M derived: sum of 3 quarters · filed 2019-05-14 | $22.19M derived: sum of 4 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | $6.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $11.27M derived: sum of 2 quarters · filed 2019-03-15 | $16.23M derived: sum of 3 quarters · filed 2019-03-15 | $20.59M 10-K · filed 2019-03-15 | |||||
| 2017-09-30 | $4.80M 10-Q · filed 2018-11-06 | $9.76M derived: sum of 2 quarters · filed 2018-11-06 | $14.12M 10-Q · filed 2018-11-06 | ||||||
| 2017-06-30 | $4.97M 10-Q · filed 2018-08-14 | $9.32M 10-Q · filed 2018-08-14 | |||||||
| 2017-03-31 | $4.35M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |